Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy
Clinical trial NCT05836753 · UNKNOWN
Trial details
- NCT number
- NCT05836753
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-07
- Primary completion
- 2023-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.